Dana-Farber Cancer Institute: Duplicated and Altered Images in NIH Grant Claims

Dana-Farber Cancer Institute agreed to pay $15 million to resolve allegations involving duplicated and altered images in NIH grant claims. The Justice Department tied the case to misinformation in 14 scientific journal articles. The institute admitted image and data misrepresentations, insufficient research oversight and unallowable grant spending. If you know the experiment behind a published figure, or the application that used it to obtain funding, our whistleblower experts can connect those parts of the story.

The Department of Justice announced the civil settlement on December 16, 2025. The allegations covered grant representations from 2014 through 2024. Dana-Farber, a cancer treatment and research center headquartered in Boston, receives federal research funding, including grants from the National Institutes of Health.

A whistleblower brought the case. The resulting agreement sets out what Dana-Farber admitted about the research and what the government alleged about the claims for money.

What the NIH Grant Claims Represented

The NIH grant claims concerned both how Dana-Farber spent research funding and what it said to obtain funding. The settlement agreement separates those paths, assigning each group of grants to a different employee serving as a principal investigator or project director.

In this civilian grant fraud case, the terms concerned scientific oversight, allowable spending and the accuracy of research descriptions. The person responsible for the experiments and the person familiar with the grant account can see different parts of the same representation.

The Grants That Paid for the Research

Dana-Farber admitted spending funds from six National Institutes of Health grants on unallowable expenses connected to publications with misrepresented images and data. Researchers working under a supervising investigator used those grants for the underlying research. The institute admitted that the supervisor failed to exercise sufficient oversight over both the research and preparation of the publications.

Attachment A lists the publications resulting from this funded research alongside the grant groups. For an insider, the agreement connects a familiar paper to the funding behind the work.

The Applications That Obtained Funding

The other path concerned four National Institutes of Health grants obtained through applications that discussed a journal article without disclosing its misrepresented or duplicated images and data. A different Dana-Farber researcher served as principal investigator or project director for these awards.

The applications certified that their statements were true, complete and accurate. Dana-Farber admitted that the National Institutes of Health reviewed and relied on those materials when deciding to award the grants. That reliance puts the research description directly inside the funding decision.

The applications described research in The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells, published in Nature Medicine in 2015. An article about earlier experiments became part of the institution’s case for federal support. The omitted information concerned the evidence those experiments supposedly produced.

How the Images Were Reused or Altered

Dana-Farber admitted that publications reused images for different experimental conditions, duplicated them for different testing conditions, mice or timepoints, and rotated, magnified or stretched them. The image and the experiment it purported to show had parted company.

For the article cited in the applications, the institute’s admissions are particularly concrete:

The same image doing duty as both control and test sample. We expect taxpayers to fund research, not the same picture dressed up as different evidence. The agreement ties those image problems to what the applications left out and what the National Institutes of Health relied on.

For a laboratory insider, the revealing detail may be the condition attached to a figure, the identity of the mouse or the experiment behind a blot band. Someone who knows the original work can explain a contradiction that is easy to miss when reading the application alone. We connect that scientific knowledge to the institution’s funding representations.

What Is a False Certification?

A false certification tells the government that a requirement has been met when it has not. Here, the government alleged that Dana-Farber falsely certified compliance with grant terms concerning oversight and allowable expenses, and submitted funding applications containing false and misleading statements.

The government’s account connects the assurances to claims submitted to the National Institutes of Health. One assurance concerned responsibility for the scientific conduct of the projects. Another concerned how grant money would be spent. The applications also carried assurances about the truth and accuracy of their contents.

That is why the grant file matters alongside the published paper. The scientific description, the institution’s certification and the funding decision belong in the same account. In assessing a research-grant whistleblower case, we examine what the institution represented, what the underlying work showed and how that difference reached the request for money.

Why Oversight and Allowable Expenses Matter

Dana-Farber’s grant terms required principal investigators to oversee and assume responsibility for the proper conduct of federally funded projects. They also required the institution to use grant funds only for allowable expenses. The institute’s admissions connect insufficient supervision to research and publications that resulted in unallowable spending.

That gives a research administrator a different view of the case from the scientist comparing images. The administrator may know which project supported the work and how the expense was charged. The supervisor’s responsibility, the publication and the grant account meet at the same project.

Dana-Farber also agreed not to charge federal contracts for the costs of defending and settling this case.

What Proof Do You Need as a Whistleblower?

For a case like Dana-Farber’s, the useful evidence connects the research image or data to the publication, grant application, certification and funding. We work through those connections with you, whether your knowledge begins with an experiment, a submission or an expense charged to an award.

Your knowledge may explain a connection the documents alone cannot.

Other Research Grant Fraud Cases

Duke University provides a related example. Its research-misconduct settlement concerned allegations that fabricated or falsified mouse research supported National Institutes of Health and Environmental Protection Agency grant claims. In the UC Davis grant settlement, the government alleged incomplete disclosures about overlapping research funding and which grants produced reported accomplishments. Each case connects a particular representation about research to the government’s money. Dana-Farber’s agreement supplies its own unusually specific account of the images, oversight and applications.

Cooperation Credit in the Dana-Farber Settlement

Dana-Farber received cooperation credit under the Justice Department’s False Claims Act guidelines. The agreement describes voluntary disclosures of additional research-misconduct allegations, acceptance of responsibility and remedial measures.

The U.S. Attorney’s Office for the District of Massachusetts and the Justice Department’s Civil Division handled the matter. The Justice Department also acted on behalf of the Department of Health and Human Services Office of Inspector General in the agreement.

How Much Money Can a Whistleblower Get From a Qui Tam Lawsuit?

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. In the Dana-Farber settlement, the Justice Department said the whistleblower would receive about $2.6 million.

That whistleblower reward is a share of the recovery from the institution.

The Experiment You Know, the Claim NIH Saw

If you recognize an image, a research account or an application that tells a different story from the work behind it, we can help turn that discrepancy into your strongest research-grant whistleblower case. We stay with you through the pursuit of a recovery and bring in research-grant fraud whistleblower lawyers who understand scientific evidence, funding representations and institutional oversight. Speak to one of our Whistleblower Experts about the experiment you know and the claim the National Institutes of Health saw.